参考文献/References:
[1]马丽媛,王增武,樊静,等.《中国心血管健康与疾病报告2021》概要[J].中国介入心脏病学杂志,2022,30(7):481-496.[2]毕思玲.基于临床科研一体化系统的胰岛素抵抗相关疾病的证型分布、用药规律和有效处方分子机理分析[D].济南:山东中医药大学,2022.[3]于昊伟,张晓宇,李国军,等.降压定眩片对原发性高血压病患者胰岛素抵抗及血清瘦素水平的影响[J].解放军医药杂志,2017,29(12):89-92.[4]陆新,云宇.调气通路法结合西药治疗原发性高血压病胰岛素抵抗的临床研究[J].湖南中医杂志,2021,37(10):1-4,11.[5]王亦菲,郭丽君,高风,等.20种常用中成药治疗高血压病的临床研究证据图分析[J].中国中药杂志,2022,47(18):5097-5105.[6]陆新,蒋嘉诚.高血压病伴胰岛素抵抗中医内治法及用药配伍特点文献分析[J].北京中医药,2019,38(6):577-580.[7]段小容,余振球,司晓云,等.对高血压防治指南的认识[J].中华高血压杂志,2022,30(9):818-823.[8]邓通,汪洋,黄笛,等.临床实践指南制订方法——GRADE方法理论篇[J].中国循证心血管医学杂志,2018,10(12):1441-1449.[9]王云云,邓通,黄桥,等.临床实践指南制订方法——GRADE在诊断试验系统评价中的应用[J].中国循证心血管医学杂志,2019,11(3):275-279.[10]李文晞,吴伟,黄衍寿,等.补肾益心片改善高血压病胰岛素抵抗30例临床观察[J].新中医,2002,34(7):34-35.[11]王芸素.补肾益心片改善高血压病患者胰岛素抵抗的临床研究[D].广州:广州中医药大学,2002.[12]李华芳.血压平胶囊治疗高血压病伴胰岛素抵杭的临床研究[D].长沙:湖南中医药大学,2009.[13]肖艳.防己黄芪胶囊调节高血压代谢异常的临床研究[D].广州:广州中医药大学,2002.[14]谭胜真,谭元生,刘鑫,等.复方七芍降压片治疗高血压病伴胰岛素抵抗[J].南华大学学报(医学版),2010,38(4):518-520,523.[15]魏晓娜.加味二至丸对高血压绝经后患者胰岛素抵抗影响的研究[D].广州:广州中医药大学,2016.[16]杨学青.降压脉净冲剂治疗高血压的临床研究[D].北京:北京中医药大学,2003.[17]张治祥,马宏秀.芪黄颗粒治疗气阴两虚血热肝热型高血压病60例[J].陕西中医,2008,29(6):663-665.[18]郭志华,袁肇凯,王东生.四泰片治疗高血压病胰岛素抵抗的临床研究[J].中成药,2004,26(2):162-164.[19]吴桂梅.血脂康胶囊对高血压糖调节受损患者胰岛素分泌及胰岛素敏感性的影响[D].南京:南京中医药大学,2013.[20]唐蜀华,蒋卫民,陈晓虎,等.针箭颗粒改善高血压病胰岛素抵抗的临床研究[J].中国中西医结合杂志,2000,20(7):511-514.[21]田颖,郭栋,彭伟,等.中成药治疗原发性高血压的系统评价再评价[J].中华高血压杂志,2022,30(10):964-975.[22]马晓聪,吴福佳,郑景辉,等.高血压胰岛素抵抗患者中医证素分布规律及相关影响因素的研究[J].右江民族医学院学报,2022,44(5):719-723,734.[23]国家心血管病医疗质量控制中心.《2021年中国心血管病医疗质量报告》概要[J].中国循环杂志,2021,36(11):1041-1064.[24]中华中医药学会,《胃复春治疗萎缩性胃炎癌前病变临床应用专家共识》项目组.胃复春治疗萎缩性胃炎癌前病变临床应用专家共识[J].中医杂志,2023,64(2):212-216.
相似文献/References:
[1]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(13):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[2]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Journal of Medical Information,2018,31(13):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[3]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(13):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[4]赵连强,雍凯龙.天麻钩藤饮治疗高血压病的临床研究[J].医学信息,2018,31(22):158.[doi:10.3969/j.issn.1006-1959.2018.22.047]
ZHAO Lian-qiang,YONG Kai-long.Clinical Study on Tianma Gouteng Decoction in Treating Hypertension[J].Journal of Medical Information,2018,31(13):158.[doi:10.3969/j.issn.1006-1959.2018.22.047]
[5]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、
白介素-6的相关性研究[J].医学信息,2019,32(15):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and
Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Journal of Medical Information,2019,32(13):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
[6]刘柏基,熊波波.代谢综合征与良性前列腺增生合并下尿路症状的关系
及治疗研究[J].医学信息,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
LIU Bai-ji,XIONG Bo-bo.Relationship between Metabolic Syndrome and Benign Prostatic Hyperplasia with
Lower Urinary Tract Symptoms and Treatment[J].Journal of Medical Information,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
[7]赵 猛,孙 娟,褚 璇.苯扎贝特改善2型糖尿病合并高甘油三酯血症患者
胰岛素抵抗的临床分析[J].医学信息,2019,32(17):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
ZHAO Meng,SUN Juan,CHU Xuan.Clinical Analysis of Bezafibrate in Improving Insulin Resistance in Patients with
Type 2 Diabetes Mellitus Complicated with Hypertriglyceridemia[J].Journal of Medical Information,2019,32(13):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
[8]李淑娟,王爱芹,杨学军,等.子宫内膜息肉发病相关危险因素临床分析[J].医学信息,2019,32(13):119.[doi:10.3969/j.issn.1006-1959.2019.13.035]
LI Shu-juan,WANG Ai-qin,YANG Xue-jun,et al.Clinical Analysis of Risk Factors Related to the Incidence of Endometrial Polyps[J].Journal of Medical Information,2019,32(13):119.[doi:10.3969/j.issn.1006-1959.2019.13.035]
[9]陈 月,任 伟.胰岛素抵抗与肌少症关系的研究[J].医学信息,2019,32(23):42.[doi:10.3969/j.issn.1006-1959.2019.23.011]
CHEN Yue,REN Wei.Study on the Relationship Between Insulin Resistance and Sarcopenia[J].Journal of Medical Information,2019,32(13):42.[doi:10.3969/j.issn.1006-1959.2019.23.011]
[10]李 玲,宋光耀.健康体检者胰岛素抵抗与血脂异常的相关性及血脂最佳分界值的探讨[J].医学信息,2020,33(01):94.[doi:10.3969/j.issn.1006-1959.2020.01.028]
LI Ling,SONG Guang-yao.Correlation Between Insulin Resistance and Dyslipidemia and the Best Cut-off Value of Blood Lipids in Healthy People[J].Journal of Medical Information,2020,33(13):94.[doi:10.3969/j.issn.1006-1959.2020.01.028]